Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the fourth quarter and full year of 2025.
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD ...
Heron’s Key, a retirement community in Gig Harbor, is expected to break ground on a major facility expansion by July, ...
One strange marsh plant can keep itself near room temperature even in freezing weather. Here’s the biology behind its ...
New analysis by the AHDB has highlighted the significant extra costs and disruption that could result from a ban on the use of carbon dioxide in pig ...
By targeting data centres in the Gulf, Iran has created global uncertainty about the resilience, sovereignty and security of ...
Norwich — Ahead of a scheduled mediation session between the city and its volunteer firefighters, attorneys on both sides weighed in on what their clients hope to get out of the private meeting. If ...
TANZANIA'S tax system plays a significant role in financing public services and infrastructure development across the nation. However, despite its importance, the country faces administrative ...
Douglas Schick, President and Chief Executive Officer of PEDEVCO, stated, "2025 was a transformational year for PEDEVCO as we executed our development program and closed the Juniper merger in the ...
Greg Abel's first Berkshire Hathaway Shareholder Letter was notably detailed, signaling strong operational command. Click for my latest analysis of BRK.A stock.
Cardinal Infrastructure Group Inc. (NASDAQ: CDNL) ("Cardinal" or the "Company"), today announced full year 2025 financial ...
Tax hikes on income, property, cigarettes and more? Columbus-Franklin County committee suggests new taxes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results